Processa Pharmaceuticals Statistics
Total Valuation
PCSA has a market cap or net worth of $6.70 million. The enterprise value is $4.96 million.
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PCSA has 2.66 million shares outstanding. The number of shares has increased by 878.52% in one year.
| Current Share Class | 2.66M |
| Shares Outstanding | 2.66M |
| Shares Change (YoY) | +878.52% |
| Shares Change (QoQ) | +16.25% |
| Owned by Insiders (%) | 2.90% |
| Owned by Institutions (%) | 22.15% |
| Float | 2.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.90 |
| P/TBV Ratio | 2.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.98
| Current Ratio | 0.98 |
| Quick Ratio | 0.85 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -464.99% and return on invested capital (ROIC) is -295.74%.
| Return on Equity (ROE) | -464.99% |
| Return on Assets (ROA) | -193.89% |
| Return on Invested Capital (ROIC) | -295.74% |
| Return on Capital Employed (ROCE) | -569.59% |
| Weighted Average Cost of Capital (WACC) | 9.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.18M |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.23% in the last 52 weeks. The beta is 0.96, so PCSA's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | -67.23% |
| 50-Day Moving Average | 2.75 |
| 200-Day Moving Average | 4.43 |
| Relative Strength Index (RSI) | 45.36 |
| Average Volume (20 Days) | 69,029 |
Short Selling Information
The latest short interest is 116,594, so 4.38% of the outstanding shares have been sold short.
| Short Interest | 116,594 |
| Short Previous Month | 135,440 |
| Short % of Shares Out | 4.38% |
| Short % of Float | 4.52% |
| Short Ratio (days to cover) | 1.75 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.47M |
| Pretax Income | -14.11M |
| Net Income | -14.11M |
| EBITDA | -14.47M |
| EBIT | -14.47M |
| Earnings Per Share (EPS) | -$7.54 |
Full Income StatementBalance Sheet
The company has $1.69 million in cash and n/a in debt, with a net cash position of $1.69 million or $0.64 per share.
| Cash & Cash Equivalents | 1.69M |
| Total Debt | n/a |
| Net Cash | 1.69M |
| Net Cash Per Share | $0.64 |
| Equity (Book Value) | 2.54M |
| Book Value Per Share | 0.95 |
| Working Capital | -41,687 |
Full Balance SheetCash Flow
| Operating Cash Flow | -12.25M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1,204 |
| Net Borrowing | -5,066 |
| Free Cash Flow | -12.25M |
| FCF Per Share | -$4.60 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
